Products

Swara

AI-native

AI calling agents that call every lead in minutes.

aicallingagents.co.in AI Models & Agents / Voice Agents

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Usage-based
No monthly subscription pricing
Launched
9mo ago
2026-03-06 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@troikatechai
  • New product launchLaunch

    Mar 6 · 9mo agoWebsite

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct38%
  • Organic Search29%
  • Referrals13%
  • Social7%
  • Other13%

Countries

  • India100%

Search

Domain authority —Domain registered 2026-03-06

KeywordMonthly volume
troika tech360
troika tech services230

Traffic data: Vaneform

Pricing

Starter
Unknown
up to 10,00,000 credits
Growth
Unknown
10,00,000+ credits
Business
Unknown
50,00,000+ credits
Corporate
Unknown
2,00,00,000+

Trial: None · Observed 2026-11-06 · Source page

Pages & changes

Tracked since 2026-08-13

Key pages

Weekly snapshots
Home
aicallingagents.co.in/ Snapshot 2026-11-07

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Swara cost?
Starter: Unknown; Growth: Unknown; Business: Unknown; Corporate: Unknown. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Swara get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Swara and what platforms does it support?
Swara is catalogued under Voice Agents: AI calling agents that call every lead in minutes.. Supported platforms: Web.

Related products in this category

AI Models & Agents / Voice Agents

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.